📊 Score Breakdown
Offering Ability
20
Cash Runway
65
Float Risk
2
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
47%
🔄 Reverse Split
65%
• 50-day avg $0.13 below $1 exchange minimum
• 10 months cash with weak price
📉 Score Deterioration
40%
• Score rose 17 points recently (worsening)
💰 Capital Raise
15%
• Under 12 months cash (10mo)
💹 Market Data
Market Cap$53.25M
Shares Outstanding372.66M
Float337.02M
Cash$3.67M
Debt$228.0K
Short InterestN/A
🏛 Institutional Holdings
18.7% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
📉 Short Interest
Short Interest386.3K
Days to Cover1.3
% of Float0.1%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
No recent SEC insights
📰 Recent News
No recent news
🔬 More Research for RDEXF
📊 RDEXF FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 RDEXF Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.